Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: A cost-effectiveness assessment in two European regions

BMC Health Services Research

Volumn 12, Issue 1, 2012, Pages

  Perrier, Lionel ^a,f,j   Buja, Alessandra ^b   Mastrangelo, Giuseppe ^b   Vecchiato, Antonella ^c   Sandon, Paolo ^b   Ducimetière, Françoise ^a   Blay, Jean Yves ^a   Gilly, François Nol ^d   Siani, Carole ^e   Biron, Pierre ^a   Ranchère Vince, Dominique ^f   Decouvelaere, Anne Valérie ^f   Thiesse, Philippe ^f   Bergeron, Christophe ^g   Dei Tos, Angelo Paolo ^h   Coindre, Jean Michel ⁱ   Rossi, Carlo Riccardo ^b   Ray Coquard, Isabelle ^a,k  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITY OF PADOVA   (Italy)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^d CENTRE HOSPITALIER LYON SUD   (France)

^e UNIVERSITÉ DE LYON   (France)

^f CENTRE LÉON BÉRARD   (France)

^g Institut d'Hemato Oncologie Pediatrique   (France)

^h Hospital of Treviso   (Italy)

ⁱ INSTITUT BERGONIÉ   (France)

^j GATE Lyon Saint Etienne   (France)

^k UNIVERSITÉ DE LYON   (France)

more..

Author keywords

Adherence; Cancer; Clinical practice guidelines; Compliance; Cost effectiveness; Sarcoma

Indexed keywords

AGED; ARTICLE; CANCER STAGING; CLINICAL PRACTICE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; ECONOMICS; FEMALE; FRANCE; HUMAN; ITALY; MALE; MIDDLE AGED; PATHOLOGY; PRACTICE GUIDELINE; RESIDENTIAL CARE; RETROSPECTIVE STUDY; SARCOMA; SOFT TISSUE TUMOR; STANDARD; STATISTICS; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; CATCHMENT AREA (HEALTH); COST-BENEFIT ANALYSIS; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FRANCE; GUIDELINE ADHERENCE; HUMANS; ITALY; MALE; MIDDLE AGED; NEOPLASM STAGING; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS; TUMOR BURDEN;

EID: 84858986934     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-12-82     Document Type: Article

References (31)

1. A European project on incidence, treatment, and outcome of sarcoma. Mastrangelo G, Fadda E, Cegolon L, Montesco MC, Ray-Coquard I, Buja A, Fedeli U, Frasson A, Spolaore P, Rossi CR, BMC Publ Health 2010 10 188 10.1186/1471-2458-10-188
2. Standards, Options et Recommandations pour la prise en charge des patients adultes atteints de sarcome des tissus mous, de sarcome utérin ou de tumeur stromale gastro-intestinale. FNCLCC, 1995 http://www.sor-cancer.fr/
3. Italian National Research Council in Italy. http://progettooncologia.cnr. it/bridge/attivita-direzione.html
4. Medical practice variations: what the literature tells us (or does not) about what are warranted and unwarranted variations. Mercuri M, Gafni A, J Eval Clin Pract 2011 17 671 677 10.1111/j.1365-2753.2011.01689.x 21501341
5. A controlled "before-after" study: impact of a clinical guidelines programme and regional cancer network organization on medical practice. Ray-Coquard I, Philip T, Ray-Coquard I, Philip T, De LG, Froger X, Suchaud JP, Voloch A, Mathieu-Daudé H, Fervers B, Farsi F, Browman GP, Chauvin F, Br J Cancer 2002 86 313 321 10.1038/sj.bjc.6600057 11875690 (Pubitemid 34185109)
6. Persistence of medical change at implementation of clinical guidelines on medical practice: a controlled study in a cancer network. Ray-Coquard I, Philip T, De LG, Froger X, Suchaud JP, Voloch A, Mathieu-Daudé H, Lurkin A, Farsi F, Bertrand P, Chauvin F, J Clin Oncol 2005 23 4414 4423 10.1200/JCO.2005.01.040 15994151 (Pubitemid 46207016)
7. Policy, management, and clinical practice implications get priority attention of health services researchers. Kaegi L, QRB Qual Rev Bull 1991 17 297 304 1683698
8. Medical practice guidelines: current activities and future directions. Audet AM, Greenfield S, Field M, Ann Intern Med 1990 113 709 714 2221652 (Pubitemid 20363644)
9. Impact of a clinical guidelines program for breast and colon cancer in a French cancer center. Ray-Coquard I, Philip T, Lehmann M, Fervers B, Farsi F, Chauvin F, JAMA 1997 278 1591 1595 10.1001/jama.1997.03550190055044 9370505 (Pubitemid 27490729)
10. Causes and consequences of deviation from multidisciplinary care in thoracic oncology. Osarogiagbon RU, Phelps G, McFarlane J, Bankole O, J Thorac Oncol 2011 6 510 516 10.1097/JTO.0b013e31820b88a7 21258245
11. Guidelines for the management of soft tissue sarcomas. Grimer R, Judson I, Peake D, Seddon B, Sarcoma 2010 201 506182
12. Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ray-Coquard I, Thiesse P, Ranchere-Vince D, Chauvin F, Bobin JY, Sunyach MP, Carret JP, Mongodin B, Marec-Bérard P, Philip T, Blay JY, Ann Oncol 2004 15 307 315 10.1093/annonc/mdh058 14760127 (Pubitemid 38262633)
13. Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: a population-based study. Jansen-Landheer ML, Krijnen P, Oostindir MJ, Kloosterman-Boele WM, Noordijk EM, Nooij MA, Steup WH, Taminiau AH, Vree R, Hogendoorn PC, Tollenaar RA, Gelderblom H, Eur J Surg Oncol 2009 35 1326 1332 10.1016/j.ejso.2009.05.002 19525085
14. The management of soft tissue sarcomas. Cutts S, Andrea F, Piana R, Haywood R, Surgeon 2012 10 25 32 10.1016/j.surge.2011.09.006 22137871
15. Does adherence to the guideline recommendation for active treatments improve the quality of care for patients with acute low back pain delivered by physical therapists? Fritz JM, Cleland JA, Brennan GP, Med Care 2007 45 973 980 10.1097/MLR.0b013e318070c6cd 17890995
16. The expanding pharmaceutical arsenal in the war on cancer. Lichtenberg F, NBER 2004 Working Paper n°10328
17. Does health care spending improve health outcomes? Evidence from English programme budgeting data. Martin S, Rice N, Smith PC, J Health Econ 2008 27 826 842 10.1016/j.jhealeco.2007.12.002 18261812
18. Methods for the economics evaluation of health care programme. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL, New-York: Oxford University Press 3 2005
19. Regione del Veneto, Nomenclatore Tariffario Prestazioni Specialistiche Ambulatoriali. http://www.regione.veneto.it/NR/rdonlyres/180C6757-EB04-4AB2- 8404-681093D15379/0/ALLEGATO/1/vigenti/delibera.pdf
20. Classification commune des actes médicaux. http://www.ameli.fr/ accueil-de-la-ccam/trouver-un-acte/consultation-par-chapitre.php?add = 16.2.5
21. Arrêté du 2 janvier 2008 relatif au tarif de cession des produits sanguins labiles. Journal officiel de la République française 10 février 2008, N°35 [ http://www.journal-officiel. gouv.fr/frameset.html ]
22. Choix méthodologiques pour l'évaluation économique la HAS. Haute autorité de santé (HAS), http://www.has-sante.fr/ portail/upload/docs/application/pdf/2011-11/guide/methodo/vf.pdf
23. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Claxton K, Sculpher M, McCabe C, Briggs A, Akehurst R, Buxton M, Brazier J, O'Hagan T, Health Econ 2005 14 339 347 10.1002/hec.985 15736142 (Pubitemid 40514748)
24. The NICE cost-effectiveness threshold: what it is and what that means. McCabe C, Claxton K, Culyer AJ, PharmacoEconomics 2008 26 733 744 10.2165/00019053-200826090-00004 18767894
25. National Institute for Health and Clinical Excellence. http://www.nice.org.uk/media/68D/29/The/guidelines/manual/2009/-/Chapter/7/ Assessing/cost/effectiveness.pdf
26. Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer. Salloum RG, Smith TJ, Jensen GA, Lafata JE, Lung Cancer 2011
27. Litwin MS; Urologic Diseases in America Project: Compliance with guidelines for patients with bladder cancer: Variation in the delivery of care. Chamie K, Saigal CS, Lai J, Hanley JM, Setodji CM, Konety BR, Cancer 2011 117 5392 5401 10.1002/cncr.26198 21780079
28. Migeot V; REPERES Group: Breast cancer care compared with clinical Guidelines: an observational study in France. Lebeau M, Mathoulin- Pélissier S, Bellera C, Tunon-de-Lara C, Daban A, Lipinski F, Jaubert D, Ingrand P, BMC Publ Health 2011 11 45 10.1186/1471-2458-11-45
29. Short-run associations between medical care expenditures and adherence to clinical practice guideline-based measures for diabetes. Ozminkowski RJ, Wang S, Marder WD, Azzolini J, Value Health 2000 3 Suppl 1 29 38 16464207
30. Why don't physicians follow clinical practice guidelines? A framework for improvement. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR, JAMA 1999 282 1458 1465 10.1001/jama.282.15.1458 10535437 (Pubitemid 29493800)
31. Towards global consensus in the treatment of gastrointestinal stromal tumor. Reichardt P, Blay JY, Mehren M, Expert Rev Anticancer Ther 2010 10 221 232 10.1586/era.09.171 20131998